as 05-14-2025 9:43am EST
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Founded: | 1996 | Country: | United States |
Employees: | N/A | City: | GERMANTOWN |
Market Cap: | 392.5M | IPO Year: | N/A |
Target Price: | $2.00 | AVG Volume (30 days): | 3.5M |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.11 | EPS Growth: | N/A |
52 Week Low/High: | $0.25 - $1.40 | Next Earning Date: | 05-08-2025 |
Revenue: | $23,682,000 | Revenue Growth: | 1.64% |
Revenue Growth (this year): | 60.14% | Revenue Growth (next year): | 36.55% |
SENS Breaking Stock News: Dive into SENS Ticker-Specific Updates for Smart Investing
GuruFocus.com
5 days ago
Zacks
6 days ago
Associated Press Finance
6 days ago
GlobeNewswire
6 days ago
GuruFocus.com
7 days ago
MedTech Dive
14 days ago
GlobeNewswire
15 days ago
Medical Device Network
15 days ago
The information presented on this page, "SENS Senseonics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.